Figure 5
From: Characterization of liposomal carriers for the trans-scleral transport of Ranibizumab
Ex vivo transport of Ranibizumab loaded liposomal formulations across seven days. The liposomes localized at the episcleral area showed some degree of intrascleral diffusion while the Ranibizumab from the loaded liposomes was able to diffuse trans-sclerally.
